ArticleNature2023
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
Open access · bronzeAbstract read
In one paragraph
Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers.
0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed
29.5field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
116 citing papers in PubMed, 154 citations in OpenAlex.
- SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback.The Journal of infectious diseases · 2024Trial
- Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines.The Journal of infectious diseases · 2024Trial
- Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.Nature communications · 2024Trial
- Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results.Nature medicine · 2023Trial
- Near real-time data on the human neutralizing antibody landscape to influenza virus in summer of 2026 shows antigenic advance of H3N2 subclade K region D mutants and H1N1 D.3.1.1 Sa mutants.bioRxiv : the preprint server for biology · 2026Article
- Potent type-specific de novo antibodies complement broadly reactive imprinted antibodies in immune responses to SARS-CoV-2 variants.Nature immunology · 2026Article
- Variant-specific spike conformational dynamics shape memory B cell selection during recall.bioRxiv : the preprint server for biology · 2026Article
- DNA oligonucleotides block viral entry of SARS-CoV-2 Omicron variants.PLoS pathogens · 2026Article
- Intranasal boosting induces variant-specific responses in SARS-CoV-2 vaccine-imprinted mice.Nature communications · 2026Article
- BPTF is essential for vaccine-induced germinal center B cell responses.Journal of immunology (Baltimore, Md. : 1950) · 2026Article
- Immunosenescence and Vaccine Efficacy in Aging: Dynamic Interplay of Gut Microbiota and mTOR Signaling Pathways.Aging cell · 2026Review
- Clonal dynamics of germinal center refueling by secondary immunization.bioRxiv : the preprint server for biology · 2026Article
- Article
- HKU1 immune imprinting is associated with post-COVID symptoms after SARS-CoV-2 infection.iScience · 2026Article
- Immunological memory to vaccines.Immunity · 2026Review
- Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques.Immunity · 2026Article
- Repeated COVID-19 vaccine boosters elicit variant-specific memory B cells in humans.Cell reports · 2026Article
- The B cell receptor-mTOR signaling axis restricts the accumulation of lung tissue-resident memory B cells after influenza infection.Science immunology · 2026Article
- Prospective Biomarkers of SARS-CoV-2 Vaccine Seroconversion in Patients with Haematological Malignancies.Vaccines · 2026Article
- Longitudinal profiling of antigen receptor gene repertoire dynamics in kidney transplant recipients after multiple SARS-CoV-2 vaccinations.ImmunoHorizons · 2026Article
56 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Update of
Authors and funding
33 authors at 3 institutions in 1 country.
Wafaa B Alsoussi *Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Sameer Kumar Malladi *Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0001-5131-4518
Julian Q ZhouDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0001-9602-2092
Zhuoming LiuDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0001-8198-0976
Baoling YingDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Wooseob KimDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0002-9199-1000
Aaron J SchmitzDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0002-8077-6751
Tingting LeiDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Stephen C HorvathDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Alexandria J SturtzDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Katherine M McIntireDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Birk EvavoldDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Fangjie HanDepartment of Emergency Medicine, Washington University School of Medicine, St Louis, MO, USA.
Suzanne M ScheafferDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Isabella F FoxDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Senaa F MirzaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0003-3319-5388
Luis Parra-RodriguezDivision of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA.
Raffael NachbagauerModerna, Cambridge, MA, USA.
Biliana NestorovaModerna, Cambridge, MA, USA.
Spyros ChalkiasModerna, Cambridge, MA, USA.
Christopher W FarnsworthDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Michael K KlebertInfectious Disease Clinical Research Unit, Washington University School of Medicine, St Louis, MO, USA.
Iskra PusicDivision of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Benjamin S StrnadMallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0003-2308-1299
William D MiddletonMallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA.
Sharlene A TeefeyMallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA.
Sean P J WhelanDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0003-1564-8590
Michael S DiamondDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0002-8791-3165
Robert ParisModerna, Cambridge, MA, USA.
Jane A O'HalloranDivision of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0001-8265-9471
Rachel M PrestiDivision of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0002-5469-0727
Jackson S TurnerDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. turner.j@wustl.edu.ORCID 0000-0002-4396-6265
Ali H EllebedyDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. ellebedy@wustl.edu.ORCID 0000-0002-6129-2532
Washington University in St. Louis · USModerna Therapeutics (United States) · USMallinckrodt (United States) · US
Funding
Household Respiratory Virus SARS-CoV-2 Transmission and Immunity Sub-Study (HRTS)U01AI144616 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GORDON, AUBREE L, THOMAS, PAUL G. · 2019 to 2025
$43.7MHuman antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2R01AI157155 · NIAID · WASHINGTON UNIVERSITY · PI BARIC, RALPH S, CROWE, JAMES E · 2020 to 2024
$6.0MDYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSESU01AI150747 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI, ANTIA, RUSTOM NOSHIR · 2020 to 2024
$5.9MProgramming Durable Immune Responses To VaccinationU01AI141990 · NIAID · WASHINGTON UNIVERSITY · PI Ali Hassan Ellebedy · 2019 to 2026
$5.3MStructural interrogation of vaccine- and infection-induced B cell responsesR01AI168178 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Goran Bajic · 2022 to 2026
$3.9MMechanism and Inhibition of SARS-CoV-2 EntryR01AI163019 · NIAID · WASHINGTON UNIVERSITY · PI KIRCHHAUSEN, TOMAS, WHELAN, SEAN PJ · 2021 to 2025
$3.8MNIAID NIH HHS R01 AI157155NIAID NIH HHS R01 AI163019NIAID NIH HHS R01 AI168178NIAID NIH HHS U01 AI141990NIAID NIH HHS U01 AI144616NIAID NIH HHS U01 AI150747
Abstract
The primary two-dose SARS-CoV-2 mRNA vaccine series are strongly immunogenic in humans, but the emergence of highly infectious variants necessitated additional doses and the development of vaccines aimed at the new variants
Indexed as
B-LymphocytesCOVID-19COVID-19 VaccinesGerminal CenterImmunization, SecondaryAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralEpitopes, B-LymphocyteHumansMemory B CellsPlasma CellsSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesEpitopes, B-LymphocyteSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2
Identifiers
What Socratic holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.